FindTrial
Sign In

Study on survival benefit of compound Kushen injection in treatment of advanced colorectal cancer based on Real world registration platform: Analysis of population characteristics of compound Kushen injection based on real world registration platform

Study on survival benefit of compound Kushen injection in treatment of advanced colorectal cancer based on Real world registration platform: Analysis of population characteristics of compound Kushen injection based on real world registration platform

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080584
Enrollment
Unknown
Registered
2024-02-01
Start date
2023-09-08
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Case series:No

Sponsors

Guang 'anmen Hospital, China Academy of Chinese Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Real World registration Research: ? Pathological diagnosis of colorectal cancer; ? Sign the informed consent, cooperate with the questionnaire, compliance is good. 2. Cross-sectional study: ? From real world registration research; ? The total dose of compound Kushen injection (Shanxi Zhendong Pharmaceutical Co., LTD.) was =200mL.

Exclusion criteria

Exclusion criteria: 1. Patients with multiple cancers; 2. Patients with serious primary diseases of heart, cerebrovascular, liver, kidney and hematopoietic system; 3. Mental patients and people with intellectual and language disabilities; 4. Repeat patients.

Design outcomes

Primary

MeasureTime frame
Overall survival;Disease-Free Survival;—

Secondary

MeasureTime frame
Cumulative recurrence and metastasis rates and survival rates at 1, 2 and 3 years;Quality of life and symptoms of colorectal cancer;Peripheral blood inflammatory index;Prognostic nutritional index;—

Countries

China

Contacts

Public ContactLi Jie

Guang 'anmen Hospital, China Academy of Chinese Medical Science

qfm2020jieli@yeah.net+86 10 8800 1192

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026